{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:40:19Z","timestamp":1793860819679,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic subdural haematoma (CSDH) is a common neurosurgical problem, increasingly prevalent due to an ageing population. Conservative management is an option for asymptomatic or mild cases, though data on outcomes is limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim\/Objective<\/jats:title>\n            <jats:p>This study aims to address critical gaps in understanding around conservatively managedCSDH and whether there are features that can predict progression and the longer-term prognosis of these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective cohort study was performed at a major trauma centre in the UK. All patients with chronic subdural haematoma referred from March 2019 to March 2021 were included and grouped into surgical or conservative management. Demographic, outcome, and radiological data were collected from patient records and compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 289 patients, 90 had surgery and 199 were managed conservatively. Conservative patients were older (84 vs 77\u00a0years, p\u2009&lt;\u20090.0001), had more comorbidities (4 vs 2, p\u2009&lt;\u20090.0001), higher frailty (CFS\u2009&gt;\u20096: 45% vs 10%, p\u2009&lt;\u20090.0001), and greater anti-thrombotic use (57% vs 42%, p\u2009=\u20090.0175). Mortality was significantly higher in the conservative group at all time points including one month (16% vs 2%, p\u2009&lt;\u20090.0001), one year (42% vs 12%, p\u2009&lt;\u20090.0001) and two years (55% vs 21%, P\u2009&lt;\u20090.0001). Surgical patients had significantly greater midline shift (10\u00a0mm vs 2.6\u00a0mm, p\u2009&lt;\u20090.0001), and haematoma depth (24\u00a0mm vs 11\u00a0mm, p\u2009&lt;\u20090.0001). Only 3% of conservative patients crossed over to surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study highlights the high mortality rate in conservatively managed CSDH, with frailty as a key indicator for early death. The low crossover to surgery questions the necessity of radiological monitoring in conservatively managed CSDH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00701-025-06577-6","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T06:14:12Z","timestamp":1749276852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["What happens to conservatively managed chronic subdural haematoma"],"prefix":"10.1007","volume":"167","author":[{"given":"Jack","family":"Read","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Edlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"6577_CR1","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.1016\/j.wneu.2018.02.106","volume":"113","author":"Z Asan","year":"2018","unstructured":"Asan Z (2018) Growth potential of subdural hematomas under clinical observation: which subdural hematomas tend to grow and why they do. World Neurosurg 113:e598\u2013e603","journal-title":"World Neurosurg"},{"issue":"4","key":"6577_CR2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00062-022-01138-1","volume":"32","author":"M Bechstein","year":"2022","unstructured":"Bechstein M, McDonough R, Fiehler J, Zanolini U, Rai H, Siddiqui A, Shotar E, Rouchaud A, Goyal M, Gellissen S (2022) Radiological evaluation criteria for chronic subdural hematomas. Clin Neuroradiol 32(4):923\u2013929","journal-title":"Clin Neuroradiol"},{"issue":"6","key":"6577_CR3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3171\/2017.8.JNS17477","volume":"129","author":"A Bin Zahid","year":"2018","unstructured":"Bin Zahid A, Balser D, Thomas R, Mahan MY, Hubbard ME, Samadani U (2018) Increase in brain atrophy after subdural hematoma to rates greater than associated with dementia. J Neurosurg 129(6):1579\u20131587","journal-title":"J Neurosurg"},{"issue":"12","key":"6577_CR4","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1007\/s00701-022-05373-w","volume":"164","author":"J Blaauw","year":"2022","unstructured":"Blaauw J, Jacobs B, den Hertog HM, van der Gaag NA, Jellema K, Dammers R, Kho KH, Groen RJM, van der Naalt J, Lingsma HF (2022) Mortality after chronic subdural hematoma is associated with frailty. Acta Neurochir (Wien) 164(12):3133\u20133141","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"6577_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3171\/2016.8.JNS16134","volume":"127","author":"PM Brennan","year":"2017","unstructured":"Brennan PM, Kolias AG, Joannides AJ, Shapey J, Marcus HJ, Gregson BA, Grover PJ, Hutchinson PJ, Coulter IC (2017) The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 127(4):732\u2013739","journal-title":"J Neurosurg"},{"issue":"11","key":"6577_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1474-4422(24)00291-6","volume":"23","author":"M Canevelli","year":"2024","unstructured":"Canevelli M, Jackson-Tarlton C, Rockwood K (2024) Frailty for neurologists: perspectives on how frailty influences care planning. Lancet Neurol 23(11):1147\u20131157","journal-title":"Lancet Neurol"},{"issue":"1","key":"6577_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/02688697.2016.1208806","volume":"31","author":"DYC Chan","year":"2017","unstructured":"Chan DYC, Chan DTM, Sun TFD, Ng SCP, Wong GKC, Poon WS (2017) The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study. Br J Neurosurg 31(1):72\u201377","journal-title":"Br J Neurosurg"},{"issue":"1","key":"6577_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91(1):8\u201335","journal-title":"Psychother Psychosom"},{"issue":"1","key":"6577_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12883-020-01669-5","volume":"20","author":"FM Chen","year":"2020","unstructured":"Chen FM, Wang K, Xu KL, Wang L, Zhan TX, Cheng F, Wang H, Chen Z-B, Gao L, Yang XF (2020) Predictors of acute intracranial hemorrhage and recurrence of chronic subdural hematoma following burr hole drainage. BMC Neurol 20(1):92","journal-title":"BMC Neurol"},{"issue":"1","key":"6577_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12877-020-01801-7","volume":"20","author":"S Church","year":"2020","unstructured":"Church S, Rogers E, Rockwood K, Theou O (2020) A scoping review of the clinical frailty scale. BMC Geriatr 20(1):393","journal-title":"BMC Geriatr"},{"issue":"1","key":"6577_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","volume":"14","author":"E Edlmann","year":"2017","unstructured":"Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14(1):108","journal-title":"J Neuroinflammation"},{"key":"6577_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.wneu.2020.06.140","volume":"141","author":"J Feghali","year":"2020","unstructured":"Feghali J, Yang W, Huang J (2020) Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 141:339\u2013345","journal-title":"World Neurosurg"},{"issue":"9","key":"6577_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMoa2409845","volume":"392","author":"D Fiorella","year":"2025","unstructured":"Fiorella D, Monteith SJ, Hanel R et al (2025) Embolization of the middle meningeal artery for chronic subdural hematoma. N Engl J Med 392(9):855\u2013864","journal-title":"N Engl J Med"},{"issue":"3","key":"6577_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2214\/ajr.153.3.589","volume":"153","author":"E Fobben","year":"1989","unstructured":"Fobben E, Grossman R, Atlas S, Hackney D, Goldberg H, Zimmerman R, Bilaniuk L (1989) MR characteristics of subdural hematomas and hygromas at 1.5 T. Am J Roentgenol 153(3):589\u2013595","journal-title":"Am J Roentgenol"},{"key":"6577_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1249332","author":"M Foppen","year":"2023","unstructured":"Foppen M, Bandral HV, Slot K-AM, Vandertop WP, Verbaan D (2023) Success of conservative therapy for chronic subdural hematoma patients: a systematic review. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1249332","journal-title":"Front Neurol"},{"issue":"6","key":"6577_CR16","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1007\/s00415-024-12307-2","volume":"271","author":"M Foppen","year":"2024","unstructured":"Foppen M, Lodewijkx R, Bandral HV, Yah K, Slot KM, Vandertop W, Verbaan D (2024) Factors associated with success of conservative therapy in chronic subdural hematoma: a single-center retrospective analysis. J Neurol 271(6):3586\u20133594","journal-title":"J Neurol"},{"issue":"7369","key":"6577_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/bmj.325.7369.868","volume":"325","author":"MJ Goldacre","year":"2002","unstructured":"Goldacre MJ (2002) Mortality after admission to hospital with fractured neck of femur: database study. BMJ 325(7369):868\u2013869","journal-title":"BMJ"},{"issue":"2","key":"6577_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/STROKEAHA.108.516286","volume":"40","author":"WJP Henneman","year":"2009","unstructured":"Henneman WJP, Sluimer JD, Cordonnier C, Baak MME, Scheltens P, Barkhof F, van der Flier WM (2009) MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 40(2):492\u2013498","journal-title":"Stroke"},{"issue":"6","key":"6577_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1227\/neu.0000000000002144","volume":"91","author":"J Henry","year":"2022","unstructured":"Henry J, Amoo M, Kissner M, Deane T, Zilani G, Crockett MT, Javadpour M (2022) Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases. Neurosurgery 91(6):842\u2013855","journal-title":"Neurosurgery"},{"issue":"12","key":"6577_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2176\/nmc.45.621","volume":"45","author":"Y Hirashima","year":"2005","unstructured":"Hirashima Y, Kurimoto M, Nagai S, Hori E, Origasa H, Endo S (2005) Effect of platelet-activating factor receptor antagonist, etizolam, on resolution of chronic subdural hematoma-a prospective study to investigate use as conservative therapy-. Neurol Med Chir (Tokyo) 45(12):621\u2013626","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"27","key":"6577_CR21","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1056\/NEJMoa2020473","volume":"383","author":"PJ Hutchinson","year":"2020","unstructured":"Hutchinson PJ, Edlmann E, Bulters D et al (2020) Trial of dexamethasone for chronic subdural hematoma. N Engl J Med 383(27):2616\u20132627","journal-title":"N Engl J Med"},{"issue":"5","key":"6577_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/jcm13051269","volume":"13","author":"P Iozzo","year":"2024","unstructured":"Iozzo P, Spina N, Cannizzaro G, Gambino V, Patinella A, Bambi S, Vellone E, Alvaro R, Latina R (2024) Association between boarding of frail individuals in the emergency department and mortality: a systematic review. J Clin Med 13(5):1269","journal-title":"J Clin Med"},{"issue":"2","key":"6577_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.13004\/kjnt.2015.11.2.87","volume":"11","author":"M-W Ju","year":"2015","unstructured":"Ju M-W, Kim S-H, Kwon H-J, Choi S-W, Koh H-S, Youm J-Y, Song S-H (2015) Comparision between brain atrophy and subdural volume to predict chronic subdural hematoma: volumetric CT imaging analysis. Korean J Neurotrauma 11(2):87","journal-title":"Korean J Neurotrauma"},{"issue":"10","key":"6577_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrneurol.2014.163","volume":"10","author":"AG Kolias","year":"2014","unstructured":"Kolias AG, Chari A, Santarius T, Hutchinson PJ (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10(10):570\u2013578","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"6577_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.13004\/kjnt.2022.18.e24","volume":"18","author":"SM Kwon","year":"2022","unstructured":"Kwon SM, Lee MH, Seo Y, Il KY, Oh H-J, Kim KH, Choi K-S, Chong K (2022) A radiological assessment of chronic subdural hematomas. Korean J Neurotrauma 18(1):12\u201321","journal-title":"Korean J Neurotrauma"},{"key":"6577_CR26","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.clineuro.2020.105899","volume":"195","author":"ERA Laldjising","year":"2020","unstructured":"Laldjising ERA, Cornelissen FMG, Gadjradj PS (2020) Practice variation in the conservative and surgical treatment of chronic subdural hematoma. Clin Neurol Neurosurg 195:105899","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"6577_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/02699050310001645801","volume":"18","author":"K-S Lee","year":"2004","unstructured":"Lee K-S (2004) Review natural history of chronic subdural haematoma. Brain Inj 18(4):351\u2013358","journal-title":"Brain Inj"},{"issue":"1","key":"6577_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3171\/2010.8.JNS10298","volume":"114","author":"LB Miranda","year":"2011","unstructured":"Miranda LB, Braxton E, Hobbs J, Quigley MR (2011) Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 114(1):72\u201376","journal-title":"J Neurosurg"},{"key":"6577_CR29","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/j.wneu.2020.05.060","volume":"141","author":"SN Neifert","year":"2020","unstructured":"Neifert SN, Chaman EK, Hardigan T, Ladner TR, Feng R, Caridi JM, Kellner CP, Oermann EK (2020) Increases in subdural hematoma with an aging population\u2014the future of American cerebrovascular disease. World Neurosurg 141:e166\u2013e174","journal-title":"World Neurosurg"},{"issue":"2","key":"6577_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ckj\/sfx134","volume":"11","author":"AC Nixon","year":"2018","unstructured":"Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A (2018) Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J 11(2):236\u2013245","journal-title":"Clin Kidney J"},{"key":"6577_CR31","unstructured":"Office for National Statistics (2024) National life tables: England. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies\/datasets\/nationallifetablesenglandreferencetables. Accessed 6 Jun 2024"},{"key":"6577_CR32","doi-asserted-by":"publisher","first-page":"100372","DOI":"10.1016\/j.wnsx.2024.100372","volume":"23","author":"B Pahwa","year":"2024","unstructured":"Pahwa B, Kazim SF, Vellek J et al (2024) Frailty as a predictor of poor outcomes in patients with chronic subdural hematoma (cSDH): A systematic review of literature. World Neurosurg X 23:100372","journal-title":"World Neurosurg X"},{"key":"6577_CR33","doi-asserted-by":"crossref","unstructured":"Parry D, Baskaran R, Lima A, Dagnan R, Jaber H, Manivannan S, Zaben M (2023) Asymptomatic chronic subdural haematoma - does it need neurosurgical intervention? Br J Neurosurg 39(2):204\u2013209","DOI":"10.1080\/02688697.2023.2210224"},{"key":"6577_CR34","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.wneu.2020.01.160","volume":"138","author":"CCT Petralia","year":"2020","unstructured":"Petralia CCT, Manivannan S, Shastin D, Sharouf F, Elalfy O, Zaben M (2020) Effect of steroid therapy on risk of subsequent surgery for neurologically stable chronic subdural hemorrhage\u2014retrospective cohort study and literature review. World Neurosurg 138:e35\u2013e41","journal-title":"World Neurosurg"},{"issue":"9","key":"6577_CR35","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00701-020-04398-3","volume":"162","author":"M Rauhala","year":"2020","unstructured":"Rauhala M, Hel\u00e9n P, Huhtala H, Heikkil\u00e4 P, Iverson GL, Niskakangas T, \u00d6hman J, Luoto TM (2020) Chronic subdural hematoma\u2014incidence, complications, and financial impact. Acta Neurochir (Wien) 162(9):2033\u20132043","journal-title":"Acta Neurochir (Wien)"},{"key":"6577_CR36","doi-asserted-by":"crossref","unstructured":"Roca F, Lang P-O, Chassagne P (2019) Chronic neurological disorders and related comorbidities: role of age-associated physiological changes. In: Dekosky ST, Asthana S (eds) Handb Clin Neurol. Elsevier, pp 105\u2013122","DOI":"10.1016\/B978-0-12-804766-8.00007-8"},{"issue":"3","key":"6577_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5770\/cgj.23.463","volume":"23","author":"K Rockwood","year":"2020","unstructured":"Rockwood K, Theou O (2020) Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr J 23(3):254\u2013259","journal-title":"Can Geriatr J"},{"issue":"2","key":"6577_CR38","first-page":"274","volume":"91","author":"F Salaffi","year":"2020","unstructured":"Salaffi F, Farah S, Di Carlo M (2020) Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology. Acta Biomed 91(2):274\u2013296","journal-title":"Acta Biomed"},{"issue":"4","key":"6577_CR39","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2020.7.FOCUS20237","volume":"49","author":"A Scerrati","year":"2020","unstructured":"Scerrati A, Visani J, Ricciardi L, Dones F, Rustemi O, Cavallo MA, De Bonis P (2020) To drill or not to drill, that is the question: nonsurgical treatment of chronic subdural hematoma in the elderly. A systematic review. Neurosurg Focus 49(4):E7","journal-title":"Neurosurg Focus"},{"issue":"8","key":"6577_CR40","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/gerona\/glaa293","volume":"76","author":"NA Shlobin","year":"2021","unstructured":"Shlobin NA, Kedda J, Wishart D, Garcia RM, Rosseau G (2021) Surgical management of chronic subdural hematoma in older adults: a systematic review. J Gerontol A 76(8):1454\u20131462","journal-title":"J Gerontol A"},{"issue":"0304","key":"6577_CR41","doi-asserted-by":"publisher","first-page":"w14398","DOI":"10.57187\/smw.2017.14398","volume":"147","author":"J Soleman","year":"2017","unstructured":"Soleman J, Nocera F, Mariani L (2017) The conservative and pharmacological management of chronic subdural haematoma: a systematic review. Swiss Med Wkly 147(0304):w14398","journal-title":"Swiss Med Wkly"},{"key":"6577_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.12688\/wellcomeopenres.18478.1","volume":"8","author":"DJ Stubbs","year":"2023","unstructured":"Stubbs DJ, Davies BM, Dixon-Woods M et al (2023) Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma. Wellcome Open Res 8:390","journal-title":"Wellcome Open Res"},{"issue":"9","key":"6577_CR43","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00701-021-04879-z","volume":"163","author":"DJ Stubbs","year":"2021","unstructured":"Stubbs DJ, Vivian ME, Davies BM, Ercole A, Burnstein R, Joannides AJ (2021) Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta Neurochir (Wien) 163(9):2629\u20132637","journal-title":"Acta Neurochir (Wien)"},{"key":"6577_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.744266","author":"G Tang","year":"2022","unstructured":"Tang G, Chen J, Li B, Fang S (2022) The efficacy of adjuvant corticosteroids in surgical management of chronic subdural hematoma: a systematic review and meta-analysis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.744266","journal-title":"Front Neurol"},{"issue":"4","key":"6577_CR45","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12325-022-02057-w","volume":"39","author":"D Wang","year":"2022","unstructured":"Wang D, Tian Y, Wei H et al (2022) Risk factor analysis of the conservative treatment in chronic subdural hematomas: a substudy of the ATOCH trial. Adv Ther 39(4):1630\u20131641","journal-title":"Adv Ther"},{"issue":"7","key":"6577_CR46","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/europace\/euac022","volume":"24","author":"C Wilkinson","year":"2022","unstructured":"Wilkinson C, Wu J, Clegg A, Nadarajah R, Rockwood K, Todd O, Gale CP (2022) Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis. EP Europace 24(7):1065\u20131075","journal-title":"EP Europace"},{"issue":"6","key":"6577_CR47","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s13760-023-02293-z","volume":"123","author":"X Zhang","year":"2023","unstructured":"Zhang X, Sha Z, Gao C, Yuan J, He L, Huang J, Jiang R (2023) Factors influencing wait-and-watch management in mild primary chronic subdural hematoma: a retrospective case\u2013control study. Acta Neurol Belg 123(6):2277\u20132286","journal-title":"Acta Neurol Belg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06577-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-025-06577-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06577-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:02:51Z","timestamp":1749319371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-025-06577-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6577"],"URL":"https:\/\/doi.org\/10.1007\/s00701-025-06577-6","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered and approved by the University Hospitals Plymouth NHS Trust audit department who determined ethical approval was not required. As the study involved anonymised data collected as part of routine care, patient consent was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no personal, financial, or institutional interests to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"164"}}